<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7441">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00926328</url>
  </required_header>
  <id_info>
    <org_study_id>CRO-0507-PL-SP-CT-BS</org_study_id>
    <nct_id>NCT00926328</nct_id>
  </id_info>
  <brief_title>Comparative Efficacy of a Toothpaste That Reduces Plaque and Gingivitis</brief_title>
  <official_title>Comparative Efficacy of a Toothpaste That Reduces Plaque and Gingivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colgate Palmolive</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Colgate Palmolive</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the performance of two toothpastes in controlling
      established gingivitis and dental plaque in adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Gingivitis Index</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Units on a scale 0 to 3 (0 = no inflammation ,
1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing.
3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plaque Index</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>A -Experimental toothpaste</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>triclosan/copolymer/fluoride toothpaste</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B - control toothpaste</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sodium fluoride only toothpaste (placebo)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triclosan, fluoride</intervention_name>
    <description>Six Month study, brush twice daily</description>
    <arm_group_label>A -Experimental toothpaste</arm_group_label>
    <other_name>Colgate Total Advanced Freshening toothpaste</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoride</intervention_name>
    <description>twice daily usage</description>
    <arm_group_label>B - control toothpaste</arm_group_label>
    <other_name>Crest Cavity Protection toothpaste</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Availability for the six-month duration of the study.

          -  Good general health.

          -  Minimum of 20 uncrowned permanent natural teeth (excluding third molars).

          -  Initial gingivitis index of at least 1.0 as determined by the use of the Loe and
             Silness Gingival Index.

          -  Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein
             Plaque Index (Turesky Modification).

          -  Signed Informed Consent Form.

        Exclusion Criteria:

          -  Presence of orthodontic bands.

          -  Presence of partial removable dentures.

          -  Tumor(s) of the soft or hard tissues of the oral cavity.

          -  Advanced periodontal disease (purulent exudate,tooth mobility, and/or extensive loss
             of

          -  periodontal attachment or alveolar bone).

          -  Five or more carious lesions requiring immediate restorative treatment.

          -  Use of antibiotics any time during the one month prior to entry into the study.

          -  Participation in any other clinical study or test panel within the one month prior to
             entry

          -  into the study.

          -  Pregnant women or women who are breast feeding.

          -  Receive a dental prophylaxis in the past two weeks prior to baseline examinations.

          -  History of allergic to personal care/consumer products or their ingredients.

          -  Taking any prescription medicines. That might interfere with the study outcome.

          -  Individuals with an existing medical condition which prohibits them from not eating
             or drinking for periods up to 4 hours.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Augusto E Boneta, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dental Research Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Fernando Autran</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 8, 2013</lastchanged_date>
  <firstreceived_date>September 26, 2008</firstreceived_date>
  <firstreceived_results_date>September 26, 2008</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gingivitis and Plaque</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Triclosan</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Performed by the Research Department School of Dentistry UPR</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Experimental Treatment</title>
          <description>triclosan/copolymer/fluoride toothpaste</description>
        </group>
        <group group_id="P2">
          <title>Placebo Control</title>
          <description>sodium fluoride toothpaste</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Experimental Treatment</title>
          <description>triclosan/copolymer/fluoride toothpaste</description>
        </group>
        <group group_id="B2">
          <title>Placebo Control</title>
          <description>sodium fluoride toothpaste</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
                <measurement group_id="B2" value="60"/>
                <measurement group_id="B3" value="120"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="58"/>
                <measurement group_id="B2" value="58"/>
                <measurement group_id="B3" value="116"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="34.72" spread="8.51"/>
                <measurement group_id="B2" value="35.95" spread="10.24"/>
                <measurement group_id="B3" value="35.33" spread="9.39"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="45"/>
                <measurement group_id="B2" value="43"/>
                <measurement group_id="B3" value="88"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="15"/>
                <measurement group_id="B2" value="17"/>
                <measurement group_id="B3" value="32"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Spain</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
                <measurement group_id="B2" value="60"/>
                <measurement group_id="B3" value="120"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gingivitis Index</title>
        <description>Units on a scale 0 to 3 (0 = no inflammation ,
1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing.
3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)</description>
        <time_frame>6 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Experimental Treatment</title>
            <description>triclosan/copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Placebo Control</title>
            <description>sodium fluoride toothpaste</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="48"/>
                  <measurement group_id="O2" value="46"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Gingivitis Index</title>
            <description>Units on a scale 0 to 3 (0 = no inflammation ,
1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing.
3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1.00" spread="0.17"/>
                  <measurement group_id="O2" value="1.27" spread="0.28"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>0.05</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plaque Index</title>
        <description>Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)</description>
        <time_frame>6 Months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Experimental Treatment</title>
            <description>triclosan/copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Placebo Control</title>
            <description>sodium fluoride toothpaste</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="48"/>
                  <measurement group_id="O2" value="46"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Plaque Index</title>
            <description>Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2.22" spread="0.49"/>
                  <measurement group_id="O2" value="2.88" spread="0.52"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>0.05</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Experimental Treatment</title>
          <description>triclosan/copolymer/fluoride toothpaste</description>
        </group>
        <group group_id="E2">
          <title>Placebo Control</title>
          <description>sodium fluoride toothpaste</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>William De Vizio, DMD</name_or_title>
      <organization>Colgate Palmolive</organization>
      <phone>732-878-7901</phone>
      <email>William_Devizio@colpal.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
